Emmaus Life Sciences, Inc. (EMMA)
OTCMKTS
· Delayed Price · Currency is USD
0.0189
-0.0011 (-5.50%)
Mar 25, 2025, 10:35 AM EST
Emmaus Life Sciences Employees
As of December 31, 2023, Emmaus Life Sciences had 55 total employees, including 51 full-time and 4 part-time employees. The number of employees did not change compared to the previous year.
Employees
55
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$385,434
Profits / Employee
-$65,962
Market Cap
1.21M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 2,931 |
Elite Pharmaceuticals | 64 |
Glass House Brands | 413 |
Northwest Biotherapeutics | 25 |
CytoDyn | 9 |
Silence Therapeutics | 116 |
American Oncology Network | 1,525 |
Emmaus Life Sciences News
- 4 months ago - Emmaus Life Sciences Reports Improved Quarterly Financial Results - PRNewsWire
- 7 months ago - Emmaus Life Sciences Reports Quarterly Financial Results - PRNewsWire
- 8 months ago - Emmaus Life Sciences Announces Willis C. Lee as Chief Executive Officer - PRNewsWire
- 9 months ago - Emmaus Life Sciences Announces Outcome of FDA Inspection of Postmarketing Adverse Drug Experience Compliance Program - PRNewsWire
- 9 months ago - Emmaus Life Sciences Reports 2023 Financial Results - PRNewsWire
- 1 year ago - Emmaus Life Sciences Reports Delayed Filing of Annual Report - PRNewsWire
- 1 year ago - Emmaus Life Sciences Receives Marketing Authorization for Puerto Rico - PRNewsWire
- 1 year ago - Emmaus Life Sciences Reports Q3 2023 Financial Results - PRNewsWire